1Faber L,Welge D,Fassbender D.One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients:predictors of hemodynamic and clinical response[J].Clin Res Cardio,2007,96(12):864-873.
6Van der Lee C,Scholzel B,ten Berg JM,et al.Usefulness of clinical,echocardiographic,and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation[J].Am J Cardiol,2008,97(4):234-243.
二级参考文献20
1郭航运.心肌病学[M].杭州:浙江科学出版社,2000.40-57.
2Li ZQ,Cheng TO,Zhang WW,et al.Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.The Chinese experience in 119 patients from a single center.Int J Cardiol,2004,93:197-202.
3Faber L,Seggewiss H,Gleichmann U.Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy:results with respect to intraprocedural myocardial contrast echocardiography.Circulation,1998,98:2415-2421.
4Blanchard DG,Ross J Jr.Hypertrophic cardiomyopathy:prognosis with medical or surgical therapy.Clin Cardiol,1991,14:11-19.
5Fananapazir L,McAreavey D.Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.J Am Coll Cardiol,1998,31:259-264.
6Spirito P,Maron BJ.Perspectives on the role of new treatment strategies in hypertrophic obstructive cardiomyopathy.J Am Coll Cardiol,1999,33:1071-1075.
7Maron BJ,Nishimura RA,McKenna WJ,et al.Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy.A randomized,double-blind,crossover study (M-PATHY).Circulation,1999,99:2927-2933.
8Sigwart U.Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy.Lancet,1995,346:211-214.
9Kern MJ,Holmes DG,Simpson C,et al.Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.Catheter Cardiovasc Interv,2002,56:503-507.
10Nagano S,Miyahara K,Sohara H,et al.Angina pectoris or myocardial infarction? Pure septal infarction.J Cardiol,2002,39:277-280.
2Zhang S. Arial Fibrillation In China's Mainland: Epidemiology And CurrentManagement. Heart, 2009, 95(13):1052-1055.
3Landmesser U, Hoimes DR Jr. Left Atrial Appendage Closure: A PercutaneousTranscatheter Approach For Stroke Prevention In A Trial Fibrillation. Eur HeartJ,2012,33:698-704.
4Reddy VY, Doshi SK, Sievert H, et al. Percutaneous Left Atrial Appendage ClosureFor Stroke Prophylaxis In Patients With Atrial Fibrillation: 2.3-Year Follow-up of TheProtect AF Trial. Circulation, 2013, 127:720-729.
